Lake Alfred, FL, United States of America

Chris Kearney

This inventor holds 1 USPTO granted patent. Top assignee: The Upjohn Co.. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chris Kearney: Innovator in Plant Biotechnology

Introduction

Chris Kearney is a notable inventor based in Lake Alfred, Florida. He has made significant contributions to the field of plant biotechnology, particularly through his work on viral resistance in plants. His innovative approach has led to advancements that benefit agricultural practices.

Latest Patents

Kearney holds a patent for the coat protein gene of the cucumber mosaic virus strain WL (CMV-WL). This patent outlines the method of preparing the gene, its application in creating transgenic plants, and the transgenic plants that contain this gene. His work is crucial in developing crops that can resist viral infections, thereby enhancing food security.

Career Highlights

Chris Kearney is associated with The Upjohn Company, where he has contributed to various research initiatives. His expertise in plant genetics and virology has positioned him as a key figure in the development of transgenic plants. His patent portfolio reflects his commitment to advancing agricultural biotechnology.

Collaborations

Kearney has worked alongside notable colleagues such as Hector D. Quemada and Jerry L. Slightom. Their collaborative efforts have furthered research in plant biotechnology and have led to significant advancements in the field.

Conclusion

Chris Kearney's contributions to plant biotechnology through his innovative patent work exemplify the importance of research in enhancing agricultural practices. His efforts continue to impact the field positively, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…